Local Infusion key facts
as of Oct 2026- Operator of an ambulatory infusion therapy center intended to deliver care for chronic autoimmune diseases.
- Local Infusion is valued at approximately $131.0M as of Oct 2026 (last reported valuation).
- It has raised $44.0M; the latest was Early Stage VC ($30.0M) in May 2025.
- Notable investors include PharmStars, Transformation Capital, Nashville Entrepreneur Center, blisce/, Brand Foundry Ventures — 7 tracked in total.
- Status: Privately Held (backing).
Local Infusion's last reported valuation, May 2025. Nothing priced has surfaced since.
- ·Watch Local Infusion: the Monday email on marks, rounds and moves
Local Infusion funding rounds
No funding rounds for Local Infusion are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
Local Infusion valuation
Local Infusion's last reported valuation was $131 million in May 2025. No priced round, secondary trade or fund mark has surfaced since.
Local Infusion investors
7 investors are on record for Local Infusion, including PharmStars, Transformation Capital, Nashville Entrepreneur Center and blisce/.
About Local Infusion
Operator of an ambulatory infusion therapy center intended to deliver care for chronic autoimmune diseases. The company's platform aims to improve outcomes for patients, save time for physicians and make it all more affordable for everyone involved, enabling patients to make the treatment proper.
- Sector
- Healthcare
- HQ
- Concord, NH, United States
- Founded
- 2022
- Employees
- 50
- Website
- mylocalinfusion.com/
- Ownership
- Privately Held (backing)
Is this your company? Sign in with your work email to keep it current, or tell us what's wrong.